{"id":"W4400151534","doi":"10.1016/j.annonc.2024.05.285","title":"279MO Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in biliary tract cancer (BTC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Biliary tract cancer; Durvalumab; Chemotherapy; Term (time); Biliary tract; Topaz; Oncology; Cancer; Internal medicine; Gemcitabine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00294153,0.000782313,0.001350983,0.0005539036,0.0003961156,0.001075842,0.0006368367,0.0005355768,0.003888309],"category_scores_gemma":[0.001497643,0.0003549539,0.003898483,0.0005884484,0.0003400793,0.0005517064,0.0005873056,0.001444134,0.0004760471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009452785,"about_ca_system_score_gemma":0.001121114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002891491,"about_ca_topic_score_gemma":0.008968414,"domain_scores_codex":[0.9990599,0.0005745908,0.00004569712,0.00008352903,0.0001022124,0.0001341683],"domain_scores_gemma":[0.9988123,0.0003491407,0.000293863,0.0001434682,0.00008770614,0.0003135206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7250499,0.004972731,0.1310153,0.00134104,0.03614064,0.0002822304,0.0001701654,0.003710536,0.01017666,0.0005000344,0.0135868,0.07305405],"study_design_scores_gemma":[0.2740679,0.107647,0.5535924,0.0002075014,0.03543647,0.0005282433,0.0002660768,0.004103381,0.005017764,0.0008856438,0.01814462,0.0001029525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813429,0.004632918,0.000552371,0.0005699812,0.0001110326,0.0004540942,0.00918925,0.00005692199,0.003090672],"genre_scores_gemma":[0.976548,0.002163857,0.0007219284,0.000834852,0.0001867755,0.0004474453,0.01591701,0.00004615534,0.003134009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003888309,"threshold_uncertainty_score":0.01555651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0826210413554754,"score_gpt":0.4131257187769274,"score_spread":0.330504677421452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}